[99mTc][Tc-HYNIC-scFvD2B] vs [99mTc][Tc(CO)3(scFvD2B-HisTag)] for the imaging SPECT of prostate cancer: preliminary in vitro studies

被引：0
|
作者：
Gobbi, C. [1 ]
Melendez-Alafort, L. [2 ]
Spolaore, B. [3 ]
Salvarese, N. [1 ]
Carpanese, D. [2 ]
Rossi, V. [2 ]
Rosato, A. [2 ,4 ]
Fracasso, G. [5 ]
Bolzati, C. [1 ]
机构：
[1] CNR, Inst Condensed Matter Chem & Energy Technol, Padua, Italy
[2] IRCSS, Ist Oncol Veneto IOV, Padua, Italy
[3] Univ Padua, Dept Pharmaceut & Pharmacol Sci, Padua, Italy
[4] Univ Padua, Dept Surg Oncol & Gastroenterol, Padua, Italy
[5] Univ Padua, Dept Biomed Sci, Padua, Italy
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2023年 / 50卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
EP-0009
引用
收藏
页码：S434 / S434
页数：1
相关论文
共 50 条
  • [1] Development and Characterization of 99mTc-scFvD2B as a Potential Radiopharmaceutical for SPECT Imaging of Prostate Cancer
    Bolzati, Cristina
    Gobbi, Carolina
    Ferro-Flores, Guillermina
    Turato, Sofia
    Ocampo-Garcia, Blanca
    Carpanese, Debora
    Marzano, Cristina
    Spolaore, Barbara
    Fracasso, Giulio
    Rosato, Antonio
    Melendez-Alafort, Laura
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (01)
  • [2] ανβ3 integrin-selective RGDechi peptides labelled with [99mTc][Tc(N)(PNP)]- and [99mTc][Tc-HYNIC]- systems: an in vitro comparison
    Bolzati, C.
    Gobbi, C.
    Salvarese, N.
    Giorgio, A.
    Carpanese, D.
    Rossi, V.
    Melendez-Alafort, L.
    Rosato, A.
    Saviano, M.
    Del Gatto, A.
    Zaccaro, L.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S435 - S435
  • [3] Dosimetry estimation and preliminary clinical application of [99mTc]Tc-HYNIC-PSMA-XL-2 in prostate cancer
    Yang, Hongxing
    Gao, Zhiqi
    Xu, Xiaoping
    Liu, Chang
    Hu, Silong
    Zhang, Jianping
    Song, Shaoli
    ANNALS OF NUCLEAR MEDICINE, 2023, 37 (01) : 60 - 69
  • [4] Dosimetry estimation and preliminary clinical application of [99mTc]Tc-HYNIC-PSMA-XL-2 in prostate cancer
    Hongxing Yang
    Zhiqi Gao
    Xiaoping Xu
    Chang Liu
    Silong Hu
    Jianping Zhang
    Shaoli Song
    Annals of Nuclear Medicine, 2023, 37 : 60 - 69
  • [5] [99mTc]Tc-HYNIC-RM2: A potential SPECT probe targeting GRPR expression in prostate cancers
    Vats, Kusum
    Chakraborty, Avik
    Rakshit, Sutapa
    Damle, Archana
    Sarma, Haladhar Dev
    Satpati, Drishty
    NUCLEAR MEDICINE AND BIOLOGY, 2023, 118
  • [6] [99mTc]Tc-labeled cyc-DX600-HYNIC as a SPECT probe for ACE2-specific pancreatic cancer imaging
    Zhou, Pan
    Li, Zheng
    Li, Danni
    Xue, Shuai
    Li, Rou
    Zhang, Lan
    Bai, Qingyun
    Li, Xiao
    AMERICAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 14 (02): : 122 - 133
  • [7] [99mTc]Tc-PSMA-T4 a potential radiofarmaceutical for SPECT/CT imaging of metastatic prostate cancer
    Wojdowska, Wioletta
    Maurin, Michal
    Sikora, Arkadiusz
    Janota, Barbara
    Radzik, Marcin
    Sawicka, Agnieszka
    Pijarowska-Kruszyna, Justyna
    Garnuszek, Piotr
    Karczmarczyk, Urszula
    NUCLEAR MEDICINE AND BIOLOGY, 2023, 126 : S106 - S107
  • [8] Imaging prostate cancer (PCa) with [99mTc(CO)3]finasteride dithiocarbamate
    Shah, Syed Qaiser
    Gul-e-Raana
    Uddin, Ghias
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2018, 61 (07): : 550 - 556
  • [9] A Novel Tumor Hypoxia Imaging Agent: [99mTc]Tc(CO)3-CPA-2-NIM
    Lin, Xiao
    Tan, Xiaojie
    Wu, Fengyu
    Yu, Qian
    CURRENT RADIOPHARMACEUTICALS, 2023, 16 (04) : 300 - 307
  • [10] Direct clinical comparison of scaffold proteins [99mTc]Tc-ADAPT6 and [99mTc]Tc-(HE)3-G3 for imaging of HER2-positive breast cancer
    Tolmachev, Vladimir
    Bragina, Olga
    Schulga, Alexey
    Hober, Sophia
    Borin, Jesper
    Deyev, Sergey
    Chernov, Vladimir
    NUCLEAR MEDICINE AND BIOLOGY, 2023, 126 : S155 - S155
12345